Overview

Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to evaluate the efficacy of the polydeoxyribonucleotide in improving the healing of diabetic foot ulcers.
Phase:
Phase 4
Details
Lead Sponsor:
University of Messina